Indications & Dose:
Status epilepticus (only if other measures fail)
Adult: 75–125 mg for 1 dose, to be administered as a 2.5% (25 mg/mL) solution
Induction of anaesthesia
Adult: Initially 100–150 mg, to be administered over 10–15 seconds usually as a 2.5% (25 mg/mL) solution, followed by 100–150 mg after 0.5–1 minute if required, dose to be given in fit and premedicated adults; debilitated patients or adults over 65 years may require a lower dose or increased administration time, alternatively initially up to 4 mg/kg (max. per dose 500 mg)
Anaesthesia of short duration
Adult: Initially 100–150 mg, to be administered over 10–15 seconds usually as a 2.5% (25 mg/mL) solution, followed by 100–150 mg after 0.5–1 minute if required, dose to be given in fit and premedicated adults; debilitated patients or adults over 65 years may require a lower dose or increased administration time, alternatively initially up to 4 mg/kg (max. per dose 500 mg)
Reduction of raised intracranial pressure if ventilation controlled
Adult: 1.5–3 mg/kg, repeated if necessary
Contraindications:
Side Effects:
Cautions:
Precautions:
Interaction:
Warnings:
Adverse Effects:
Lactations:
Special Precautions:
Counselling:
Side Effects Or Adverse Reactions:
Patient And Carer Advice:
© Pakistan Drug Directory. All Rights Reserved.
Designed By: Pakistan Drug Directory Team